See also this year's filing and all EDGAR filings for this company.
PDF Report 0001674930_2022_Fulgent_Genetics_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.35469524804874253, 'aggregate_val': 58040000, 'exp_sum': 89942000, 'exp_to_value': {'IntangibleAssets': 0, 'AssetsNonCurrent': 31902000, 'AssetsCurrent': 26138000, 'PropertyPlantAndEquipment': 6234000, 'remainder_Assets': 25668000}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001674930, Fulgent Genetics Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 50,897,000 |
| 1 | AssetsNonCurrent | 10,650,000 |
| 2 | AssetsCurrent | 611,960,000 |
| 3 | PropertyPlantAndEquipment | 62,287,000 |
| 4 | remainder_Assets | 542,926,000 |
| 5 | LongTermLiabilities | 6,805,000 |
| 6 | LiabilitiesCurrent | 105,310,000 |
| 7 | remainder_Liabilities | 725,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 215,533,000 |
| 10 | GeneralAndAdministrativeExpense | 50,732,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 24,439,000 |
| 15 | ResearchAndDevelopmentExpense | 24,219,000 |
| 16 | remainder_Expenses | 176,503,000 |
| 17 | remainder_Revenues | 993,931,000 |
| 18 | remainder_NetIncome | 3,734,000 |
| 19 | remainder_ComprehensiveNetIncome | -72,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,278,720,000 |
| 1 | Liabilities | 112,840,000 |
| 2 | Expenses | 491,426,000 |
| 3 | Revenues | 993,931,000 |
| 4 | StockholdersEquity | 1,165,880,000 |
| 5 | NetIncome | 506,239,000 |
| 6 | ComprehensiveNetIncome | 506,167,000 |
| 7 | BaseVar | 1,440,361,500 |
| 8 | EconomicCapitalRatio | 5.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
